Schrodinger News

Maintaining Neutral: Assessing Schrodinger's Mixed Q1 Performance and Future Outlook

TipRanksMay 3 21:55

Craig-Hallum: Maintaining the Schrodinger (SDGR.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $35.00 to $30.00.

Zhitong FinanceMay 3 01:00

Schrodinger Analyst Ratings

BenzingaMay 3 00:59

Craig-Hallum Maintains Buy on Schrodinger, Lowers Price Target to $30

BenzingaMay 3 00:59

Maintained Buy Rating on Schrodinger: Navigating Short-Term Hurdles With Long-Term Catalysts in Sight

TipRanksMay 2 18:23

Craig-Hallum Remains a Buy on Schrodinger (SDGR)

TipRanksApr 29 20:57

R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space

Seeking AlphaApr 11 00:56

Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA) and Schrodinger (SDGR)

TipRanksApr 4 21:10

Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)

TipRanksApr 4 20:20

Schrodinger Analyst Ratings

BenzingaMar 2 01:22

Critical Insights From Schrodinger Analyst Ratings: What You Need To Know

BenzingaMar 2 01:01

Schrodinger Analyst Ratings

BenzingaFeb 29 23:44

Buy Rating Affirmed for Schrodinger Amidst Robust Software Business and Promising Clinical Milestones

TipRanksFeb 29 20:29

Schrodinger: A Neutral Rating With Revised Price Objective Amidst Growth Uncertainties

TipRanksFeb 29 18:29

Maintaining a Neutral Stance on Schrodinger Amidst Growth and Uncertainties

TipRanksFeb 29 17:15

Analysts' Opinions Are Mixed on These Healthcare Stocks: Schrodinger (SDGR), Editas Medicine (EDIT) and MacroGenics (MGNX)

TipRanksFeb 29 15:51

Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Schrodinger (SDGR)

TipRanksFeb 29 10:20

Craig-Hallum Sticks to Their Buy Rating for Schrodinger (SDGR)

TipRanksFeb 26 22:06

TD Cowen Initiates Coverage On Schrodinger With Outperform Rating, Announces Price Target of $42

BenzingaJan 26 19:59

Schrodinger Analyst Ratings

BenzingaJan 26 19:57